Topo IIα Polyclonal Antibody

    • Catalog No.:YT4701
    • Applications:WB;IHC;IF;ELISA
    • Reactivity:Human;Monkey
      • Target:
      • Topo IIα
      • Fields:
      • >>Platinum drug resistance
      • Gene Name:
      • TOP2A
      • Protein Name:
      • DNA topoisomerase 2-alpha
      • Human Gene Id:
      • 7153
      • Human Swiss Prot No:
      • P11388
      • Mouse Swiss Prot No:
      • Q01320
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human TOP2A. AA range:1-50
      • Specificity:
      • Topo IIα Polyclonal Antibody detects endogenous levels of Topo IIα protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IHC 1:100 - 1:300. IF 1:200 - 1:1000. ELISA: 1:20000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • TOP2A;TOP2;DNA topoisomerase 2-alpha;DNA topoisomerase II; alpha isozyme
      • Observed Band(KD):
      • 174kD
      • Background:
      • This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, alpha, is localized to chromosome 17 and the beta gene is localized to chromosome 3. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also pla
      • Function:
      • catalytic activity:ATP-dependent breakage, passage and rejoining of double-stranded DNA.,enzyme regulation:Specifically inhibited by the intercalating agent amsacrine.,function:Control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks.,miscellaneous:Eukaryotic topoisomerase I and II can relax both negative and positive supercoils, whereas prokaryotic enzymes relax only negative supercoils.,PTM:Phosphorylation has no effect on catalytic activity.,similarity:Belongs to the type II topoisomerase family.,subcellular location:Generally located in the nucleoplasm.,subunit:Homodimer. Interacts with COPS5.,
      • Subcellular Location:
      • Cytoplasm . Nucleus, nucleoplasm . Nucleus . Nucleus, nucleolus .
      • Expression:
      • Expressed in the tonsil, spleen, lymph node, thymus, skin, pancreas, testis, colon, kidney, liver, brain and lung (PubMed:9155056). Also found in high-grade lymphomas, squamous cell lung tumors and seminomas (PubMed:9155056).
      • Products Images
      • Western Blot analysis of various cells using Topo IIα Polyclonal Antibody diluted at 1:1000. Secondary antibody(catalog#:RS0002) was diluted at 1:20000
      • Western Blot analysis of 293 cells using Topo IIα Polyclonal Antibody diluted at 1:1000. Secondary antibody(catalog#:RS0002) was diluted at 1:20000
      • Immunofluorescence analysis of A549 cells, using TOP2A Antibody. The picture on the right is blocked with the synthesized peptide.
      • Immunohistochemistry analysis of paraffin-embedded human liver carcinoma tissue, using TOP2A Antibody. The picture on the right is blocked with the synthesized peptide.
      • Western blot analysis of lysates from HT-29 cells, using TOP2A Antibody. The lane on the right is blocked with the synthesized peptide.